FDA Drug recall D-1042-2013
IBU (TM) IBUPROFEN Tablets, USP, 800 mg, 500 -count bottle,(NDC 55111-684-05) Rx only, Distributed by Dr. Reddy's Laboratories, Inc., Bridg…
- FDA Drug
- Class II
- terminated
- Published 2013-09-25
On 2013-09-25 the FDA classified a Class II recall of IBU (TM) IBUPROFEN Tablets, USP, 800 mg, 500 -count bottle,(NDC 55111-684-05) Rx only, Distributed by Dr. Reddy's Laboratories, Inc., Bridg… by Dr Reddy S Laboratories, citing labeling: Incorrect or missing lot and/or exp date- This product is being recalled due to an incorrect expiration date of 05/2017. The correct expiration date is 10/2016.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1042-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2013-08-29 |
| Published | 2013-09-25 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Dr Reddy S Laboratories |
| Distribution | US |
Product
IBU (TM) IBUPROFEN Tablets, USP, 800 mg, 500 -count bottle,(NDC 55111-684-05) Rx only, Distributed by Dr. Reddy's Laboratories, Inc., Bridgewater, NJ 08807 USA.
Reason
Labeling: Incorrect or missing lot and/or exp date- This product is being recalled due to an incorrect expiration date of 05/2017. The correct expiration date is 10/2016.
Identifiers
| ndc | 55111-682-09 |
|---|---|
| ndc | 55111-682-01 |
| ndc | 55111-682-05 |
| ndc | 55111-683-30 |
| ndc | 55111-683-50 |
| ndc | 55111-683-09 |
| ndc | 55111-683-01 |
| ndc | 55111-683-05 |
| ndc | 55111-684-30 |
| ndc | 55111-684-50 |
| ndc | 55111-684-60 |
| ndc | 55111-684-09 |
| ndc | 55111-684-01 |
| ndc | 55111-684-05 |
| code_info | Lot # L300192; Exp. 05/2017 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1042-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.